COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
Introduction of ‘data exclusivity’ in pesticides Bill will affect farmers
Certain clauses in the Bill threaten to delay the entry of affordable generic products in the market
It will be months before there is consensus over COVID-19 vaccine patents: Experts
The United States has supported a temporary waiver on COVID-19 vaccine patents; but not all is hunky-dory, say experts
Dark underbelly of Big Pharma lobbying
Recent protests and campaigns in the US have focused on the proposal by India & South Africa at WTO to keep TRIPS in abeyance till the …
India must reap benefits of booming floriculture industry
With the size of individual farm lands diminishing by the day, horticulture holds immense potential to augment income of many small farmers
The fading mirage of a TRIPS waiver
A year later, the proposal to lift WTO’s intellectual property blocks to making COVID vaccines has not inched forward
This is how rich nations protect profits of multinational pharma firms
When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out
Beware of Japan's trade ambitions
Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines
New leaked chapter of Asia trade deal shows RCEP will undercut farmers’ control over seeds
The Regional Comprehensive Economic Partnership threatens to increase corporate power in member countries, leaving ordinary people with little rights
Coronavirus vaccines: Tech transfer is the new mantra
A tech transfer hub for mRNA vaccines is being set up in South Africa, a first for the continent; but will the pharmaceutical companies play ball?
Global pandemic treaty: Soumya Swaminathan promises draft in 18 months
WHO chief scientist says most countries on board for pact to ensure fair sharing of vaccines, data during future pandemics
‘Compromise’ on TRIPS waiver is a sellout
Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools
World leaders should choose people over profit
Rising hunger, inequality, loss of livelihoods, climate change, environmental degradation, war and vaccine inequality pushed excluded people to …
Civil society questions Modi about Indo-US joint IP working group
Letter to Modi says Indian government should be wary of higher IP standards that are typically demanded by the US administration and its trade …
Who is really afraid of the TRIPS agreement?
India has not shown the grit to fully use the inbuilt flexibilities in the WTO’s TRIPS pact to protect public health
Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth
Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …
The NATCO CL fallout
The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market
India’s 3 D Message
The Supreme Court judgment in the Novartis case clearly upholds India’s patent laws, not weakens the patent regime
The natco-pfizer test
Natco’s demand for a voluntary licence from Pfizer will establish how well the compulsory licence process works in India
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
Has Modi succumbed US’ pressure on patents?
Prime minister’s statement, agreeing to implement recommendations of India-US joint working group on intellectual property, would make …
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
WTO members agree to discuss proposal to waive patents on COVID-19 technologies
The waiver would increase access to technologies crucial to fighting the pandemic
WTO decision on access to COVID-19 drugs without strings delayed
Proposal will be formally discussed in March next year, sources say
.jpg "The natco-pfizer test")
